Home › Trial NCT06149533
Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients
- Trial IDNCT06149533
- StatusNot Yet Recruiting
- PhasePhase 3
- Study typeInterventional
- SponsorCancer Institute and Hospital, Chinese Academy of Medical Sciences
- Enrollment366
- Start date2023-11-30
- ConditionsThrombosis, Venous · Cancer · Catheter Complications
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.